RPL32P34

Across TCGA pan-cancer cohorts, RPL32P34 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPL32P34’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPL32P34 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL32P34 is over-expressed in tumor, although a few such as KIRP and KICH show the opposite, repressed pattern.

KIRC, LUSC, and KIRP are the cancer types where RPL32P34 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P34 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.115	.007	7	view →
LUSC	All	II,III,IV	+0.205	.006	5	view →
KIRP	Male	All	−0.155	.019	3	view →
KICH	All	All	−0.082	.009	3	view →
BRCA	All	III,IV	−0.165	.013	2	view →
READ	Female	All	−0.138	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RPL32P34–KIRC

Open the KIRC breakdown →